PT-141 for men: a better conversation about desire
In this article
PT-141, also called bremelanotide, has produced promising erectile responses in early studies involving men. Evidence for improving sexual desire in men remains limited. Vyleesi, the FDA-approved bremelanotide injection, has a specific indication in premenopausal women and is not approved for men. Early male research, current prescribing information.
If PT-141 has caught your attention, start with the experience you want to improve. Wanting sex, getting an erection, and reaching orgasm can call for different conversations.
Start with what has changed
An evaluation can include your sexual and medical history, medications, mental health, and an examination or testing when appropriate. Be specific about what changed and when. NIDDK: evaluating erectile dysfunction.
Our guides explore several common starting points:
- Erections are possible, but interest in sex has faded.
- Testosterone is in range, but desire still feels low.
- Desire is there, but reaching orgasm is difficult.
If getting or keeping an erection is the main concern, established ED options include sildenafil and daily tadalafil. Our PT-141 and ED medication comparison explains their different roles. NIDDK: ED treatment.
How does PT-141 work?
Bremelanotide activates melanocortin receptors, including receptors in the central nervous system. Researchers are studying how that activity relates to sexual responses. Even for its approved use in women, the exact mechanism behind improved desire is not fully understood. Vyleesi prescribing information.
What do the studies in men actually show?
Early nasal-spray research measured erections. A 2004 placebo-controlled study found increased erectile responses in healthy male participants and men with ED who responded to sildenafil. Researchers measured erections using RigiScan, rather than establishing sustained improvement in low desire. Diamond and colleagues, 2004.
Early injection research also found an erectile response. Another 2004 study evaluated subcutaneous PT-141 in healthy men and men reporting an inadequate response to sildenafil. These results supported further research into erectile function. Rosen and colleagues, 2004.
Clinical experience adds another perspective. A 2024 conference abstract reported prescribing and refill patterns at a sexual-medicine clinic. Those patterns cannot isolate a drug’s effect on desire from expectations or other care. Goldstein and Goldstein, 2024.
One frequently cited male trial has an important qualification. The journal issued an expression of concern about a 2008 study in men who had not responded to sildenafil. Its results should not be presented as settled proof. Journal notice.
Can PT-141 be combined with an erection medication?
A crossover study involving 19 men found a greater measured erectile response with intranasal PT-141 plus sildenafil than with sildenafil alone. That small, formulation-specific study does not establish every combination’s safety or effectiveness. Combination study.
Discuss the actual products with your prescriber before combining them. The medication comparison covers the evidence and prescribing considerations in more detail.
If your current erection medication is not helping, our ED medication follow-up guide explains what to review before discussing another treatment.
For gay and bisexual men: your pleasure belongs in the conversation
Maybe you miss the anticipation before a date. Maybe you want to feel more interested in initiating sex with a long-term partner. Maybe you want to understand what helps you feel engaged and present. Those are worthwhile reasons to start a conversation about your sexual health.
Whether you are single, partnered, or exploring a new chapter, your goals belong at the center of that conversation. What feels satisfying to you? What would you like more of? What has changed?
If PT-141 has caught your attention, bring that curiosity into an assessment. The research described above gives you and your clinician a starting point for discussing the medication alongside your health, experience, and other options. The studies reviewed here do not report separate results for gay or bisexual men.
You can start with:
- “I would like to feel more interested in initiating sex.”
- “I want to understand the difference between what I desire and how my body responds.”
- “These are the experiences I enjoy. How would we judge whether a treatment is helping?”
You get to define what a fulfilling sex life looks like. Bring your questions, your preferences, and the details that make it yours.
What should you know about safety and formulation?
Vyleesi’s labeling lists uncontrolled high blood pressure and known cardiovascular disease as contraindications. It can temporarily increase blood pressure, decrease heart rate, cause nausea, flushing or headache, and cause areas of darker pigmentation. It can also affect absorption of oral medicines; oral naltrexone has a specific warning. These findings warrant a medication and cardiovascular review, but they do not provide male-specific risk estimates. Prescribing information.
Share your medications, supplements, and recreational substances with the clinician. The PT-141 safety guide covers these considerations in more detail.
AnthologyRX’s compounded PT-141 contains bremelanotide, the active ingredient in Vyleesi. A licensed pharmacy prepares the medication for an individual prescription. AnthologyRX treatment details; Vyleesi prescribing information.
The finished preparation can differ in concentration, other ingredients, and delivery system. It is not FDA-approved or established as equivalent to Vyleesi in safety, effectiveness, or quality. FDA: compounded drugs.
Make the next conversation useful
Before an assessment, write down what has changed, what matters most to you, what you have tried, and your current medications. Ask what benefit would count as meaningful, when you would reassess, and what alternatives belong in the conversation.
